Deborah F. King

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Conference report: airway mucosal sampling and immune analysis.

Conference report: airway mucosal sampling and immune analysis.

Journal: Vaccine
Published: March 20, 2026

Searching for immune correlates in Lassa vaccine development - workshop report.

Searching for immune correlates in Lassa vaccine development - workshop report.

Journal: NPJ vaccines
Published: December 20, 2025

Assessing for neonatal jaundice in the community: an integrative systematic review.

Assessing for neonatal jaundice in the community: an integrative systematic review.

Journal: Midwifery
Published: April 16, 2025

Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.

Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.

Journal: The Lancet. Microbe
Published: March 22, 2024

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary.

Realising the potential of correlates of protection for vaccine development, licensure and use: short summary.

Journal: NPJ vaccines
Published: November 03, 2023

The role of correlates of protection in overcoming barriers to vaccine development and demonstrating efficacy.

The role of correlates of protection in overcoming barriers to vaccine development and demonstrating efficacy.

Journal: NPJ vaccines
Published: November 03, 2023

Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH.

Mosaic HIV-1 vaccination induces anti-viral CD8+ T cell functionality in the phase 1/2a clinical trial APPROACH.

Journal: Journal of virology
Published: October 09, 2023

Enabling the evaluation of COVID-19 vaccines with correlates of protection.

Enabling the evaluation of COVID-19 vaccines with correlates of protection.

Journal: Biologicals : journal of the International Association of Biological Standardization
Published: August 18, 2023

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.

Journal: Frontiers in immunology
Published: August 26, 2022

Human infection studies: Key considerations for challenge agent development and production.

Human infection studies: Key considerations for challenge agent development and production.

Journal: Wellcome open research
Published: April 20, 2022

Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.

Meeting Summary: Global Vaccine and Immunization Research Forum, 2021.

Journal: Vaccine
Published: April 01, 2022

Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.

Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.

Journal: PloS one
Published: August 10, 2021
Showing 1-12 of 26

Last Updated: 09/26/2026